Funding · Company
Sensorium Therapeutics, Inc.
Medford, MABiotech & Pharma
Sensorium Therapeutics, Inc. of Medford, MA has disclosed $51M across 2 Form D offerings filed with the SEC between Dec 6, 2023 and Jul 15, 2025.
$51M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$27M
Form D · Jul 15, 2025 ↗
Q3 2025
· 1 amendment, first filed Feb 12, 2025
· target $58M
$25M
Form D · Dec 6, 2023 ↗
Q4 2023
· 1 amendment, first filed Oct 4, 2022
· target $25M
Filing details
HeadquartersMedford, MAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2021SEC CIK0001874823Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →